Clark William D

Avg. Two Year Performance

243% Avg. Purchase Return
85% Compound
65% Avg. Sale Return
29% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(1%)(6%)(13%)642%243%
Purchase Success Rate4 of 52 of 51 of 51 of 51 of 5
Average Sale Return(4%)(11%)29%36%65%
Sale Success Rate6 of 119 of 1110 of 119 of 119 of 11

Genocea Biosciences, Inc.

Drugs » Drugs - Generic

President and CEO, Director:

Holdings: 304.38K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Vanda Pharmaceuticals, Inc.

Drugs » Biotechnology

Sr. VP, Chief Business Officer:

Holdings: 168.28K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Ibio, Inc.

Drugs » Drug Manufacturers - Major

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

X4 Pharmaceuticals, Inc

Other » Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--